These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 28460246)

  • 1. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout.
    Szafranski DD; Snead A; Allan NP; Gros DF; Killeen T; Flanagan J; Pericot-Valverde I; Back SE
    Addict Behav; 2017 Oct; 73():30-35. PubMed ID: 28460246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters.
    Szafranski DD; Gros DF; Acierno R; Brady KT; Killeen TK; Back SE
    Clin Psychol Psychother; 2019 Mar; 26(2):218-226. PubMed ID: 30419153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
    Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
    Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure.
    Jarnecke AM; Allan NP; Badour CL; Flanagan JC; Killeen TK; Back SE
    Addict Behav; 2019 Mar; 90():35-39. PubMed ID: 30355535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of traumatic brain injury on treatment outcomes of Concurrent Treatment for PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) in veterans.
    Gros DF; Lancaster CL; Horner MD; Szafranski DD; Back SE
    Compr Psychiatry; 2017 Oct; 78():48-53. PubMed ID: 28803041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders?
    Lancaster CL; Gros DF; Mullarkey MC; Badour CL; Killeen TK; Brady KT; Back SE
    Behav Cogn Psychother; 2020 Jan; 48(1):38-53. PubMed ID: 31010449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment predictors of dropout from prolonged exposure therapy in patients with chronic posttraumatic stress disorder and comorbid substance use disorders.
    Belleau EL; Chin EG; Wanklyn SG; Zambrano-Vazquez L; Schumacher JA; Coffey SF
    Behav Res Ther; 2017 Apr; 91():43-50. PubMed ID: 28147254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity.
    Badour CL; Flanagan JC; Gros DF; Killeen T; Pericot-Valverde I; Korte KJ; Allan NP; Back SE
    J Consult Clin Psychol; 2017 Mar; 85(3):274-281. PubMed ID: 28221062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes?
    Jeffirs SM; Jarnecke AM; Flanagan JC; Killeen TK; Laffey TF; Back SE
    Drug Alcohol Depend; 2019 Jun; 199():70-75. PubMed ID: 31009834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes?
    Bountress KE; Badour C; Flanagan J; Gilmore AK; Back SE
    Psychol Trauma; 2018 Nov; 10(6):662-665. PubMed ID: 28771018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Exposure- and Coping Skills-Based Treatments on Trauma-Related Guilt in Veterans With Co-Occurring Alcohol Use and Posttraumatic Stress Disorders.
    Capone C; Tripp JC; Trim RS; Davis BC; Haller M; Norman SB
    J Trauma Stress; 2020 Aug; 33(4):603-609. PubMed ID: 32521096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Written exposure therapy for veterans with co-occurring substance use disorders and PTSD: Study design of a randomized clinical trial.
    Meshberg-Cohen S; Cook JM; Bin-Mahfouz A; Petrakis IL
    Contemp Clin Trials; 2024 Apr; 139():107475. PubMed ID: 38365173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaginal exposure processing during Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) therapy: Examination of linguistic markers of cohesiveness.
    Gandelman EM; Miller SA; Back SE
    J Trauma Stress; 2022 Apr; 35(2):682-693. PubMed ID: 34979039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders.
    Badour CL; Flanagan JC; Allan NP; Gilmore AK; Gros DF; Killeen T; Korte KJ; Brown DG; Kolnogorova K; Back SE
    J Trauma Stress; 2022 Apr; 35(2):546-558. PubMed ID: 34773928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial.
    Kehle-Forbes SM; Nelson D; Norman SB; Schnurr PP; Shea MT; Ackland PE; Meis L; Possemato K; Polusny MA; Oslin D; Hamblen JL; Galovski T; Kenny M; Babajide N; Hagedorn H
    Contemp Clin Trials; 2022 Sep; 120():106876. PubMed ID: 35987487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders.
    Kehle-Forbes SM; Chen S; Polusny MA; Lynch KG; Koffel E; Ingram E; Foa EB; Van Horn DHA; Drapkin ML; Yusko DA; Oslin DW
    Drug Alcohol Depend; 2019 Dec; 205():107647. PubMed ID: 31675546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study design, interventions, and baseline characteristics for the Substance use and TRauma Intervention for VEterans (STRIVE) trial.
    Kehle-Forbes SM; Drapkin ML; Foa EB; Koffel E; Lynch KG; Polusny MA; Van Horn DH; Yusko DA; Charlesworth M; Blasco M; Oslin DW
    Contemp Clin Trials; 2016 Sep; 50():45-53. PubMed ID: 27444425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lagged effects of substance use on PTSD severity in a randomized controlled trial with modified prolonged exposure and relapse prevention.
    Hien DA; Smith KZ; Owens M; López-Castro T; Ruglass LM; Papini S
    J Consult Clin Psychol; 2018 Oct; 86(10):810-819. PubMed ID: 30265040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of dropout from a randomized clinical trial of cognitive processing therapy for female veterans with military sexual trauma-related PTSD.
    Holder N; Holliday R; Wiblin J; LePage JP; Surís A
    Psychiatry Res; 2019 Jun; 276():87-93. PubMed ID: 31030005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No Wrong Doors: Findings from a Critical Review of Behavioral Randomized Clinical Trials for Individuals with Co-Occurring Alcohol/Drug Problems and Posttraumatic Stress Disorder.
    Simpson TL; Lehavot K; Petrakis IL
    Alcohol Clin Exp Res; 2017 Apr; 41(4):681-702. PubMed ID: 28055143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.